Meiji Pharmaceutical University · Unclassified

Research keywordsregulatory science・systematic reviews・clinical trial design・pharmacy education・meta-analysis・breast cancer therapeutics

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Cross-sectional Study and Comparison between Japan and the United States on Special Regulatory Pathways for Expedited Drug Development and Approval.2025 · Therapeutic Innovation & Regulatory Science. 2025. https://doi.org/10.1007/s43441-025-00771-5.
• Gender differences in pharmacy professors in Japan and Korea.2025 · Lancet Reg Health West Pac. 2025 Jan 15;54:101469. doi: 10.1016/j.lanwpc.2025.101469.
• Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis.2025 · Cancer Treatment Reviews. 2025. 135: 102923.
• Comparison of regulatory approval system for medicines in emergency among Japan, the United States, the United Kingdom, Europe, and China.2024 · PLoS One. 2024. 19(9): e0309992. https://doi.org/ 10.1371/journal.pone.0309992.

• Research on product recalls of pharmaceuticals and medical devices in Japan.
• 医薬品の製造販売承認のための臨床試験のサロゲートエンドポイントに関する研究
• 本邦の抗がん剤におけるドラッグラグ、開発着手時期、審査期間の変遷と国際比較の検討
• 次期制度改正を見据えた医薬品市販後安全対策の再構築に関する研究

• Official profile